Success Metrics

Active Trials
2(100%)

Phase Distribution

Ph phase_1
2
100%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
2
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 12 (100.0%)

Trials by Status

recruiting150%
active_not_recruiting150%

Recent Activity

2 active trials
Showing 2 of 2
recruitingphase_1

TSN084 Treating Patients With Advanced Malignant Tumors

NCT06386705
active_not_recruitingphase_1

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

NCT05300438

Clinical Trials (2)

Showing 2 of 2 trials
NCT06386705Phase 1

TSN084 Treating Patients With Advanced Malignant Tumors

Recruiting
NCT05300438Phase 1

Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Active Not Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2